Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease

INTRODUCTION: Pneumococcal disease, which presents a substantial health and economic burden, is prevented through pneumococcal vaccination programs. We assessed the impact of switching from a 13-valent-based (PCV13) to lower 10-valent-based (PCV10-GlaxoSmithKline [GSK] or PCV10-Serum Institute of In...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Liping, McDade, Cheryl L., Perdrizet, Johnna E., Wilson, Michele R., Warren, Sophie A., Nzenze, Susan, Sewdas, Renilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922201/
https://www.ncbi.nlm.nih.gov/pubmed/36774428
http://dx.doi.org/10.1007/s40121-023-00767-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922201/
https://www.ncbi.nlm.nih.gov/pubmed/36774428
http://dx.doi.org/10.1007/s40121-023-00767-4

Ejemplares similares